Cargando…

Plasma Lipidomics Identifies Unique Lipid Signatures and Potential Biomarkers for Patients With Aortic Dissection

Aortic dissection (AD) is a catastrophic cardiovascular emergency with a poor prognosis, and little preceding symptoms. Abnormal lipid metabolism is closely related to the pathogenesis of AD. However, comprehensive lipid alterations related to AD pathogenesis remain unclear. Moreover, there is an ur...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Huang, Ye, Guozhu, Lai, Song-qing, Zou, Hua-xi, Yuan, Bin, Wu, Qi-cai, Wan, Li, Wang, Qun, Zhou, Xue-liang, Wang, Wen-jun, Cao, Yuan-ping, Huang, Jian-feng, Chen, Shi-li, Yang, Bi-cheng, Liu, Ji-chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581228/
https://www.ncbi.nlm.nih.gov/pubmed/34778409
http://dx.doi.org/10.3389/fcvm.2021.757022
_version_ 1784596760527634432
author Huang, Huang
Ye, Guozhu
Lai, Song-qing
Zou, Hua-xi
Yuan, Bin
Wu, Qi-cai
Wan, Li
Wang, Qun
Zhou, Xue-liang
Wang, Wen-jun
Cao, Yuan-ping
Huang, Jian-feng
Chen, Shi-li
Yang, Bi-cheng
Liu, Ji-chun
author_facet Huang, Huang
Ye, Guozhu
Lai, Song-qing
Zou, Hua-xi
Yuan, Bin
Wu, Qi-cai
Wan, Li
Wang, Qun
Zhou, Xue-liang
Wang, Wen-jun
Cao, Yuan-ping
Huang, Jian-feng
Chen, Shi-li
Yang, Bi-cheng
Liu, Ji-chun
author_sort Huang, Huang
collection PubMed
description Aortic dissection (AD) is a catastrophic cardiovascular emergency with a poor prognosis, and little preceding symptoms. Abnormal lipid metabolism is closely related to the pathogenesis of AD. However, comprehensive lipid alterations related to AD pathogenesis remain unclear. Moreover, there is an urgent need for new or better biomarkers for improved risk assessment and surveillance of AD. Therefore, an untargeted lipidomic approach based on ultra-high-performance liquid chromatograph-mass spectrometry was employed to unveil plasma lipidomic alterations and potential biomarkers for AD patients in this study. We found that 278 of 439 identified lipid species were significantly altered in AD patients (n = 35) compared to normal controls (n = 32). Notably, most lipid species, including fatty acids, acylcarnitines, cholesteryl ester, ceramides, hexosylceramides, sphingomyelins, lysophosphatidylcholines, lysophosphatidylethanolamines, phosphatidylcholines, phosphatidylinositols, diacylglycerols, and triacylglycerols with total acyl chain carbon number ≥54 and/or total double bond number ≥4 were decreased, whereas phosphatidylethanolamines and triacylglycerols with total double bond number <4 accumulated in AD patients. Besides, the length and unsaturation of acyl chains in triacylglycerols and unsaturation of 1-acyl chain in phosphatidylethanolamines were decreased in AD patients. Moreover, lysophosphatidylcholines were the lipids with the largest alterations, at the center of correlation networks of lipid alterations, and had excellent performances in identifying AD patients. The area under the curve of 1.0 and accuracy rate of 100% could be easily obtained by lysophosphatidylcholine (20:0/0:0) or its combination with lysophosphatidylcholine (17:0/0:0) or lysophosphatidylcholine (20:1/0:0). This study provides novel and comprehensive plasma lipidomic signatures of AD patients, identifies lysophosphatidylcholines as excellent potential biomarkers, and would be beneficial to the pathogenetic study, risk assessment and timely diagnosis and treatment of AD.
format Online
Article
Text
id pubmed-8581228
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85812282021-11-12 Plasma Lipidomics Identifies Unique Lipid Signatures and Potential Biomarkers for Patients With Aortic Dissection Huang, Huang Ye, Guozhu Lai, Song-qing Zou, Hua-xi Yuan, Bin Wu, Qi-cai Wan, Li Wang, Qun Zhou, Xue-liang Wang, Wen-jun Cao, Yuan-ping Huang, Jian-feng Chen, Shi-li Yang, Bi-cheng Liu, Ji-chun Front Cardiovasc Med Cardiovascular Medicine Aortic dissection (AD) is a catastrophic cardiovascular emergency with a poor prognosis, and little preceding symptoms. Abnormal lipid metabolism is closely related to the pathogenesis of AD. However, comprehensive lipid alterations related to AD pathogenesis remain unclear. Moreover, there is an urgent need for new or better biomarkers for improved risk assessment and surveillance of AD. Therefore, an untargeted lipidomic approach based on ultra-high-performance liquid chromatograph-mass spectrometry was employed to unveil plasma lipidomic alterations and potential biomarkers for AD patients in this study. We found that 278 of 439 identified lipid species were significantly altered in AD patients (n = 35) compared to normal controls (n = 32). Notably, most lipid species, including fatty acids, acylcarnitines, cholesteryl ester, ceramides, hexosylceramides, sphingomyelins, lysophosphatidylcholines, lysophosphatidylethanolamines, phosphatidylcholines, phosphatidylinositols, diacylglycerols, and triacylglycerols with total acyl chain carbon number ≥54 and/or total double bond number ≥4 were decreased, whereas phosphatidylethanolamines and triacylglycerols with total double bond number <4 accumulated in AD patients. Besides, the length and unsaturation of acyl chains in triacylglycerols and unsaturation of 1-acyl chain in phosphatidylethanolamines were decreased in AD patients. Moreover, lysophosphatidylcholines were the lipids with the largest alterations, at the center of correlation networks of lipid alterations, and had excellent performances in identifying AD patients. The area under the curve of 1.0 and accuracy rate of 100% could be easily obtained by lysophosphatidylcholine (20:0/0:0) or its combination with lysophosphatidylcholine (17:0/0:0) or lysophosphatidylcholine (20:1/0:0). This study provides novel and comprehensive plasma lipidomic signatures of AD patients, identifies lysophosphatidylcholines as excellent potential biomarkers, and would be beneficial to the pathogenetic study, risk assessment and timely diagnosis and treatment of AD. Frontiers Media S.A. 2021-10-28 /pmc/articles/PMC8581228/ /pubmed/34778409 http://dx.doi.org/10.3389/fcvm.2021.757022 Text en Copyright © 2021 Huang, Ye, Lai, Zou, Yuan, Wu, Wan, Wang, Zhou, Wang, Cao, Huang, Chen, Yang and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Huang, Huang
Ye, Guozhu
Lai, Song-qing
Zou, Hua-xi
Yuan, Bin
Wu, Qi-cai
Wan, Li
Wang, Qun
Zhou, Xue-liang
Wang, Wen-jun
Cao, Yuan-ping
Huang, Jian-feng
Chen, Shi-li
Yang, Bi-cheng
Liu, Ji-chun
Plasma Lipidomics Identifies Unique Lipid Signatures and Potential Biomarkers for Patients With Aortic Dissection
title Plasma Lipidomics Identifies Unique Lipid Signatures and Potential Biomarkers for Patients With Aortic Dissection
title_full Plasma Lipidomics Identifies Unique Lipid Signatures and Potential Biomarkers for Patients With Aortic Dissection
title_fullStr Plasma Lipidomics Identifies Unique Lipid Signatures and Potential Biomarkers for Patients With Aortic Dissection
title_full_unstemmed Plasma Lipidomics Identifies Unique Lipid Signatures and Potential Biomarkers for Patients With Aortic Dissection
title_short Plasma Lipidomics Identifies Unique Lipid Signatures and Potential Biomarkers for Patients With Aortic Dissection
title_sort plasma lipidomics identifies unique lipid signatures and potential biomarkers for patients with aortic dissection
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581228/
https://www.ncbi.nlm.nih.gov/pubmed/34778409
http://dx.doi.org/10.3389/fcvm.2021.757022
work_keys_str_mv AT huanghuang plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT yeguozhu plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT laisongqing plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT zouhuaxi plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT yuanbin plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT wuqicai plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT wanli plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT wangqun plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT zhouxueliang plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT wangwenjun plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT caoyuanping plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT huangjianfeng plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT chenshili plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT yangbicheng plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection
AT liujichun plasmalipidomicsidentifiesuniquelipidsignaturesandpotentialbiomarkersforpatientswithaorticdissection